Ovarian Cancer | Tumor

CURE’s ovarian cancer page is a go-to resource for oncology news and updates in the world of ovarian cancer Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in ovarian cancer.

FDA Approves Lynparza for Maintenance Treatment of BRCA-Mutant Gynecologic Cancers

December 20th 2018

This is the first approval of a PARP inhibitor as a first-line maintenance treatment for BRCA-mutant gynecologic cancers.

FDA Approves Diagnostic Tool for BRCA-Mutant Ovarian Cancer

December 19th 2018

The Food and Drug Administration (FDA) approved BRACAnalysis CDx to be used to identify patients with advanced ovarian cancer who have germline BRCA mutations and are eligible for first line treatment with Lynparza (olaparib) after responding to platinum-based chemotherapy.

Overcoming the Psychological Effects of Ovarian Cancer

December 4th 2018

A new program offers counseling, patient education and vetted referrals to patients and their families.

Lynparza Significantly Delays Progression in Advanced Ovarian Cancer, Study Finds

December 4th 2018

Maintenance treatment with Lynparza (olaparib) after chemotherapy has been found to significantly extend progression-free survival in newly diagnosed patients with advanced ovarian cancer and a BRCA mutation, according to a recent phase 3 study.

Learning the Lingo of Cancer

December 4th 2018

A cancer diagnosis can lead to discussions about family health history, as well as a whole new world to learn about.

Focusing on Quality of Life, Improving Outcomes in Ovarian Cancer

November 27th 2018

Patients with ovarian cancer are living longer than ever.

Legislation Seeks Medicare Recognition of Genetic Counselors to Expand Access to Care

November 26th 2018

To receive payment for counseling and increase access to services, a new bill has been introduced so that genetic counselors receive payment for counseling Medicare beneficiaries.

Giving Teeth to Oral Care

November 17th 2018

Certain cancer treatments can affect the mouth, so dental health should be a lifelong commitment.

FDA Grants Lynparza Priority Review for Frontline Maintenance in Ovarian Cancer

November 12th 2018

The FDA has granted a priority review designation to a supplemental new drug application (sNDA) for Lynparza (olaparib) tablets for use as a maintenance therapy in patients with newly-diagnosed, BRCA-positive advanced ovarian cancer who achieved a complete or partial response to standard frontline platinum-based chemotherapy.

Starting a Conversation

November 11th 2018

Families with certain genetic mutations face many complex and personal choices, including how and when to share such information with their children. Mom's Genes is here to help.

When Your Partner Has Cancer, It May Feel Like You Do Too

November 2nd 2018

Here are some tips on coping with the disease that seems to affect us all.

CURE's Top 5 Stories: October 2018

November 1st 2018

Here are the top 5 CURE stories for October 2018.

Maintenance Lynparza Improves PFS for Ovarian Cancer

October 30th 2018

The PARP inhibitor Lynparza (olaparib) significantly improved progression-free survival (PFS) as frontline maintenance therapy for women with BRCA-positive advanced ovarian cancer, according to findings from the randomized phase 3 SOLO-1 trial presented at the 2018 ESMO Congress.

Cobie Smulders: Not on My Watch

October 25th 2018

Actress partners with TESARO to launch national movement to help empower the ovarian cancer community

Joining Forces Against Hereditary Risk for Breast and Ovarian Cancer

October 24th 2018

After receiving a breast cancer diagnosis “out of the blue” in 1996, Sue Friedman would later come to find out she also has a BRCA2 genetic mutation – a discovery that would lead to the creation of an organization for individuals in a similar situation.

Discussing Hereditary Cancer Risk With Children

October 22nd 2018

Although there is never the perfect time to have a risk-related discussion with a child, one clinical psychologist explains ways in which parents can approach the difficult topic.

Managing Lymphedema: Education is the Best Treatment

October 22nd 2018

To combat the psychological effects from a lymphedema diagnosis, patients need to be equipped with the knowledge and understanding of what the condition is and how it is treated.

It's All in the Family: Discussing Cancer Risk with Extended Family Members

October 20th 2018

One family shares their experience with the discovery of a BRCA mutation, and how they discussed it among one another.

Clinical Trial Participation is Key for Hereditary Cancer Research Advancement

October 20th 2018

Although individuals may have concerns about enrolling in a study, their involvement may lead to new discoveries.

One Previvor's Journey With a BRCA Mutation

October 19th 2018

Eva Moon, a writer, musician and performing artist, discusses her genetic mutation and how it changed the direction of her life.

Illuminating Ovarian Cancer

October 18th 2018

In this episode of CURE Talks Cancer, we caught up with all three storytellers from the “Our Way Forward: Stories that Illuminate the Ovarian Cancer Experience,” storytelling event hosted through a special engagement with The Moth.

Daily Aspirin Use Could Reduce Ovarian Cancer Risk and Improve Survival

October 14th 2018

New research indicates that aspirin and nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen (Advil) or naproxen (Aleve) could not only reduce the risk of ovarian cancer, but also improve survival with daily use.

Know Your Family's Health History

October 12th 2018

After testing positive for the BRCA mutation, Pulaski has become an advocate and authored a book titled “Mom’s Genes,” which focuses on starting the conversation with children about their family’s health history.

Evening of Storytelling Speaks to Future of Cancer Research

October 9th 2018

Three storytellers offered their experiences with BRCA mutation at a Basser Center for BRCA event in New York City.

Knowing Your Hereditary Risk

October 1st 2018

In this special edition of the CURE Talks Cancer podcast, we kick off National Hereditary Breast and Ovarian Cancer Week and Previvor Day.

Hope Remains for Immunotherapy in Ovarian Cancer

September 26th 2018

Although immunotherapy’s use in ovarian cancer lags other cancer types, Matthew Powell, M.D., believes there is still promise for checkpoint blockades in this field, likely in combination with other agents.

The Cost of Ovarian Cancer Prevention

September 24th 2018

Seven years ago, I was diagnosed with Lynch syndrome, a hereditary cancer condition which significantly increases my chances of developing early-onset cancer.

To Test or Not To Test: A Thorny Question in Ovarian Cancer Maintenance

September 18th 2018

Researchers disagree on whether or not to monitor ovarian cancer survivors with frequent CA-125 tests. But this patient would rather have more information than less.

A Word from Patrick Dempsey During National Ovarian Cancer Awareness Month

September 14th 2018

Patrick Dempsey discusses National Ovarian Cancer Awareness Month.

What Saved Me Years After My Hysterectomy

September 10th 2018

Life after a hysterectomy is one of the many challenges I have had to overcome.